Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 67, Issue 1, Pages (January 2005)

Similar presentations


Presentation on theme: "Volume 67, Issue 1, Pages (January 2005)"— Presentation transcript:

1 Volume 67, Issue 1, Pages 265-271 (January 2005)
The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease  Tazeen H. Jafar, Paul C. Stark, Christopher H. Schmid, Svend Strandgaard, Anne-Lise Kamper, Giuseppe Maschio, Gavin Becker, Ronald D. Perrone, Andrew S. Levey, M.D., M.P.H.  Kidney International  Volume 67, Issue 1, Pages (January 2005) DOI: /j x Copyright © 2005 International Society of Nephrology Terms and Conditions

2 Figure 1 Effect of angiotensin-converting enzyme (ACE) inhibitor treatment. (A) Decline in urine protein excretion in patients with polycystic kidney disease (PKD). Symbols show the difference in mean decline in urine protein excretion (95% CI) at various levels of baseline urine protein excretion in patients with PKD receiving antihypertensive treatment regimens with versus those without ACE inhibitors. Results are from a multivariable model with covariates include assignment to ACE inhibitor vs. control group, gender, age, baseline systolic blood pressure, baseline urine protein excretion, baseline serum creatinine concentration, and interaction of baseline urine protein excretion and treatment with ACE inhibitors. (B) Relative risk (95% CI) of kidney disease progression in patients with PKD. Symbols show the relative risk (95% CI) of kidney disease progression (the combined outcome of doubling of baseline serum creatinine or the onset of kidney failure) at various levels of baseline urine protein excretion in patients with PKD receiving antihypertensive treatment regimens with versus those without ACE inhibitors. Results are from a multivariable model with covariates include assignment to ACE inhibitor vs. control group, gender, age, baseline systolic blood pressure, baseline urine protein excretion, baseline serum creatinine concentration, and interaction of baseline urine protein excretion and treatment with ACE inhibitors. Kidney International  , DOI: ( /j x) Copyright © 2005 International Society of Nephrology Terms and Conditions


Download ppt "Volume 67, Issue 1, Pages (January 2005)"

Similar presentations


Ads by Google